Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug 30;20(22):1370-1379.
doi: 10.4244/EIJ-D-23-00983. Online ahead of print.

Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology

Rui Campante Teles  1 , Eric Van Belle  2 , Radoslaw Parma  3 , Giuseppe Tarantini  4 , Nicolas van Mieghem  5 , Darren Mylotte  6 , Joana Delgado Silva  7 , Stephen O'Connor  8 , Lars Sondegaard  9 , Andre Luz  10 , Ignacio Jesus Amat-Santos  11 , Dabit Arzamendi  12 , Daniel Blackman  13 , Ole De Backer  9 , Vijay Kunadian  14 , Gill Louise Buchanan  15 , Phil MacCarthy  16 , Philipp Lurz  17 , Christopher Naber  18 , Alaide Chieffo  19 , Valeria Paradies  20 , Martine Gilard  21 , Flavien Vincent  2 , Chiara Fraccaro  4 , Julinda Mehilli  22 , Cristina Giannini  23 , Bruno Silva  24 , Petra Poliacikova  25 , Nicole Karam  26 , Verena Veulemans  27 , Holger Thiele  28 , Thomas Pilgrim  29 , Marleen van Wely  30 , Stefan James  31 , Michael Rahbek Schmidt  32 , Anselm Uebing  33 , Andreas Rück  34 , Alexander Ghanem  35 , Ziyad Ghazzal  36 , Francis R Joshi  9   37 , Luca Favero  38 , Renicus Hermanides  39 , Vlasis Ninios  40 , Luca Nai Fovino  4 , Rutger-Jan Nuis  5 , Pierre Deharo  41 , Petr Kala  42 , Gabby Elbaz-Greener  43 , Didier Tchétché  44 , Eustachio Agricola  45 , Matthias Thielmann  46 , Erwan Donal  47 , Nikolaos Bonaros  48 , Steven Droogmans  49 , Martin Czerny  50 , Andreas Baumbach  51 , Emanuele Barbato  52 , Dariusz Dudek  53   54
Affiliations

Percutaneous Valvular and Structural Heart Disease Interventions. 2024 Core Curriculum of the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC in collaboration with the European Association of Cardiovascular Imaging (EACVI) and the Cardiovascular Surgery Working Group (WG CVS) of the European Society of Cardiology

Rui Campante Teles et al. EuroIntervention. .

Abstract

The percutaneous treatment of structural, valvular, and non-valvular heart disease (SHD) is rapidly evolving. The Core Curriculum (CC) proposed by the EAPCI describes the knowledge, skills, and attitudes that define competency levels required by newly trained SHD interventional cardiologists (IC) and provides guidance for training centres. SHD ICs are cardiologists who have received complete interventional cardiology training. They are multidisciplinary team specialists who manage adult SHD patients from diagnosis to follow-up and perform percutaneous procedures in this area. They are competent in interpreting advanced imaging techniques and master planning software. The SHD ICs are expected to be proficient in the aortic, mitral, and tricuspid areas. They may have selective skills in either the aortic area or mitral/tricuspid areas. In this case, they must still have common transversal competencies in the aortic, mitral, and tricuspid areas. Additional SHD domain competencies are optional. Completing dedicated SHD training, aiming for full aortic, mitral, and tricuspid competencies, requires at least 18 months. For full training in the aortic area, with basic competencies in mitral/tricuspid areas, the training can be reduced to 1 year. The same is true for training in the mitral/tricuspid area, with competencies in the aortic area. The SHD IC CC promotes excellence and homogeneous training across Europe and is the cornerstone of future certifications and patient protection. It may be a reference for future CC for national associations and other SHD specialities, including imaging and cardiac surgery.

PubMed Disclaimer

Conflict of interest statement

E. Agricola has received speaker honoraria and compensation from GE HealthCare, outside the current topic. I.J. Amat-Santos has received speaker honoraria and advisory board compensation from Boston Scientific, Meril Life, Medtronic, and Abbott. A. Baumbach has received institutional research support from Biotronik; and honoraria from Faraday, Pi-Cardia and Meril Life. D. Blackman has acted as a consultant, advisory board member, and speaker for Abbott, Edwards Lifesciences, and Medtronic. N. Bonaros has received speaker honoraria from Edwards Lifesciences and Medtronic; as well as research grants from Edwards Lifesciences and Corcym. M. Czerny is consultant to Terumo Aortic, Medtronic, NEOS, and Endospan. O. De Backer has received research grants, speaker and consulting fees from Abbott, Boston Scientific, and Medtronic. P. Deharo has received honoraria from Boston Scientific, Abbott, Asahi, Medtronic and Novartis. P. Lurz has received institutional fees and research grants from Abbott, Edwards Lifesciences, and ReCor; honoraria from Edwards Lifesciences, Abbott, Innoventric, ReCor and Boehringer Ingelheim; and has stock options with Innoventric. R. Hermanides has received compensation from companies outside the current topic. S. James has received institutional research support from Edwards Lifesciences and Medtronic; and proctoring fees from Medtronic. F.R. Joshi has received honoraria and advisory board compensation from Boston Scientific; and travel support from Millbrook Medical. P. Kala declares that he has received consultant and speaker fees from Boston Scientific, Edwards Lifesciences, Sanofi, Novartis, and Servier; participated in advisory boards from Boston Scientific, Abbott, Novartis, and Servier; and received research support from Bayer, Novartis, and Amgen. N. Karam has received consultant fees from Abbott, Medtronic, Edwards Lifesciences, and Boston Scientific. A. Luz has received consultant fees from Abbott. J. Mehilli has received speaker honoraria and compensation from AstraZeneca, Boston Scientific, Daiichi Sankyo, and Shockwave. D. Mylotte has received research grants from Boston Scientific; and speaker honoraria/advisory board compensation from Medtronic, Microport, and Boston Scientific. R. Nuis has received research grant support from Vifor Pharma; and consulting fees from Edwards Lifesciences, Abbott, and Boston Scientific. V. Paradies declares research grants from Abbott to the institution; and speaker fees from Abbott and Boston Scientific. R. Parma has received speaker fees from Edwards Lifesciences. A. Rück declares institutional research and educational grants from Boston Scientific and Edwards Lifesciences; and personal speaker and consultancy fees from Boston Scientific, Abbott, Edwards Lifesciences, and Anteris. T. Pilgrim reports research, travel or educational grants to the institution without personal remuneration from Biotronik, Boston Scientific, and Edwards Lifesciences; and speaker fees and consultancy fees to the institution from Biotronik, Boston Scientific, Edwards Lifesciences, Abbott, Medtronic, Biosensors, and Highlife. G. Tarantini has received speaker honoraria/advisory board compensation from Edwards Lifesciences, Boston Scientific, Medtronic, Abbott, Philips, and Microport. D. Tchétché is consultant for Abbott, Boston Scientific, Edwards Lifesciences, and Medtronic. A. Uebing has received advisory board compensation from Medtronic. N. Van Mieghem has received research grant support from Abbott, Boston Scientific, Medtronic, AstraZeneca, and Daiichi Sankyo; and scientific advisory fees from Anteris, JenaValve, Amgen, Siemens, Pie Medical, Abbott, Boston Scientific, Medtronic, AstraZeneca, and Daiichi Sankyo. M. van Wely has received proctoring fees from Abbott; and speaker fees from Boston Scientific. V. Veulemans has received consulting fees, travel expenses, or study honoraria from Medtronic, Edwards Lifesciences, and Boston Scientific. The other authors have no conflicts of interest to declare.

Similar articles

See all similar articles

Cited by

References

    1. Van Belle, Teles RC, Pyxaras SA, Kalpak O, Johnson TW, Barbash IM, De Luca, Kostov J, Parma R, Vincent F, Brugaletta S, Debry N, Toth GG, Ghazzal Z, Deharo P, Milasinovic D, Kaspar K, Saia F, Mauri Ferre, Kammler J, Muir DF, O’Connor S, Mehilli J, Thiele H, Weilenmann D, Witt N, Joshi F, Kharbanda RK, Piroth Z, Wojakowski W, Geppert A, Di Gioia, Pires-Morais G, Petronio AS, Estevez-Loureiro R, Ruzsa Z, Kefer J, Kunadian V, Van Mieghem, Windecker S, Baumbach A, Haude M, Dudek D. EAPCI Core Curriculum for Percutaneous Cardiovascular Interventions (2020): Committee for Education and Training European Association of Percutaneous Cardiovascular Interventions (EAPCI). A branch of the European Society of Cardiology. EuroIntervention. 2021;17:23–31. - PMC - PubMed
    1. Agricola E, Ancona F, Brochet E, Donal E, Dweck M, Faletra F, Lancellotti P, Mahmoud-Elsayed H, Marsan NA, Maurovich-Hovart P, Monaghan M, Ribeiro J, Sade LE, Swaans M, Von Bardeleben, Wunderlich N, Zamorano JL, Popescu BA, Cosyns B, Edvardsen T Reviewers: This document was reviewed by members of the 2018-2020 EACVI Scientific Documents Committee. The structural heart disease interventional imager rationale, skills and training: a position paper of the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2021;22:471–9. - PubMed
    1. Leonardi S, Capodanno D, Sousa-Uva M, Vrints C, Rex S, Guarracino F, Bueno H, Lettino M, Price S, Valgimigli M, Jeppsson A. Composition, structure, and function of heart teams: a joint position paper of the ACVC, EAPCI, EACTS, and EACTA focused on the management of patients with complex coronary artery disease requiring myocardial revascularization. Eur Heart J Acute Cardiovasc Care. 2021;10:83–93. - PubMed
    1. Parma R, Zembala MO, Dąbrowski M, Jagielak D, Witkowski A, Suwalski P, Dudek D, Olszówka P, Wojakowski W, Przybylski R, Gil R, Kuśmierczyk M, Lesiak M, Sadowski J, Dobrzycki S, Ochała A, Hoffman P, Kapelak B, Kaźmierczak J, Jasiński M, Stępińska J, Szymański P, Hryniewiecki T, Kochman J, Grygier M, Zembala M, Legutko J, Różański J. Transcatheter aortic valve implantation. Expert Consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society…. Kardiol Pol. 2017;75:937–64. - PubMed
    1. Loureiro-Ga M, Veiga C, Fdez-Manin G, Jimenez VA, Juan-Salvadores P, Busto L, Baz JA, Iñiguez A. Predicting TAVI paravalvular regurgitation outcomes based on numerical simulation of the aortic annulus eccentricity and perivalvular areas. Comput Methods Biomech Biomed Engin. 2021;24:1629–37. - PubMed